Investigating genetic risks for aggressive thyroid cancer in male veterans
Genetic Risk for Aggressive Thyroid Cancer in an Understudied Male Predominant Veteran Population
This study is looking at how genes and environmental factors, like exposure to toxins, affect aggressive thyroid cancer in veterans, especially men, to help find better ways to diagnose and treat this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10919300 on NIH RePORTER |
What this research studies
This research focuses on understanding the genetic and environmental factors that contribute to aggressive thyroid cancer, particularly in a male-dominant population of veterans. By utilizing the Million Veteran Program, which includes over 950,000 enrolled veterans, the study aims to identify specific genetic markers and risk factors associated with this type of cancer. The research will analyze data from veterans, many of whom may have been exposed to environmental toxins like Agent Orange, to better understand how these factors influence cancer severity and outcomes. The ultimate goal is to improve personalized diagnosis and treatment options for those affected.
Who could benefit from this research
Good fit: Ideal candidates for this research are male veterans, particularly those with a family history of thyroid cancer or exposure to environmental toxins.
Not a fit: Patients who are not veterans or who do not have a history of thyroid cancer or related risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate risk assessments and tailored treatment strategies for aggressive thyroid cancer in veterans.
How similar studies have performed: While there is ongoing research into thyroid cancer, this specific focus on genetic risks in a male veteran population is relatively novel and has not been extensively studied.
Where this research is happening
Aurora, UNITED STATES
- VA Eastern Colorado Health Care System — Aurora, United States (Active)
Researchers
- Principal investigator: Fishbein, Lauren Michelle — VA Eastern Colorado Health Care System
- Study coordinator: Fishbein, Lauren Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.